Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $134.7M | -- | -- | $0.49 | -- |
| 10/29/2025 | Q3 | $128.3M | $130.9M | $0.71 | $0.60 | $0.11 |
| 07/31/2025 | Q2 | $138.6M | $145.5M | $0.67 | $0.66 | $0.01 |
| 05/01/2025 | Q1 | $117.2M | $121.7M | -$0.14 | $0.37 | -$0.51 |
| 02/26/2025 | Q4 | $177.2M | $180.8M | -$1.91 | $1.50 | -$3.41 |
| 10/31/2024 | Q3 | $161.4M | $161.5M | $1.07 | $1.23 | -$0.16 |
| 08/01/2024 | Q2 | $189.1M | $190.8M | $1.43 | $1.54 | -$0.11 |
| 05/02/2024 | Q1 | $170.3M | $170.6M | $0.92 | $0.99 | -$0.07 |
| 02/22/2024 | Q4 | $205.4M | $214.9M | $1.39 | $1.35 | $0.04 |
| 11/02/2023 | Q3 | $209.1M | $211.6M | $0.58 | $1.30 | -$0.72 |
| 08/03/2023 | Q2 | -- | $209M | $1.44 | -- | -- |
| 05/04/2023 | Q1 | -- | $201M | $1.39 | -- | -- |
| 02/23/2023 | Q4 | -- | $191M | $1.01 | -- | -- |
| 11/03/2022 | Q3 | -- | $201.1M | $1.06 | -- | -- |
| 08/04/2022 | Q2 | -- | $195M | $1.15 | -- | -- |
| 05/05/2022 | Q1 | -- | $195.2M | $1.69 | -- | -- |
| 02/24/2022 | Q4 | -- | $166.8M | $1.37 | -- | -- |
| 11/03/2021 | Q3 | -- | $176.6M | $1.08 | -- | -- |
| 08/04/2021 | Q2 | -- | $174.9M | $0.91 | -- | -- |
| 05/05/2021 | Q1 | -- | $108.3M | $0.90 | -- | -- |
| 02/25/2021 | Q4 | -- | $100.9M | $0.68 | -- | -- |
| 10/29/2020 | Q3 | -- | $103M | $0.61 | -- | -- |
| 07/30/2020 | Q2 | -- | $92.6M | $0.50 | -- | -- |
| 04/30/2020 | Q1 | -- | $99.1M | $0.57 | -- | -- |
| 02/26/2020 | Q4 | -- | $92.5M | $0.76 | -- | -- |
| 10/31/2019 | Q3 | -- | $90.7M | $0.48 | -- | -- |
| 07/31/2019 | Q2 | -- | $90.5M | $0.46 | -- | -- |
| 05/01/2019 | Q1 | -- | $89.1M | $0.57 | -- | -- |
| 02/27/2019 | Q4 | -- | $104.9M | $0.69 | -- | -- |
| 11/01/2018 | Q3 | -- | $95M | $0.52 | -- | -- |
| 08/02/2018 | Q2 | -- | $88.3M | $0.44 | -- | -- |
| 05/02/2018 | Q1 | -- | $88M | $0.52 | -- | -- |
| 03/01/2018 | Q4 | -- | $88.2M | $0.74 | -- | -- |
| 11/02/2017 | Q3 | -- | $86.3M | $0.82 | -- | -- |
| 08/03/2017 | Q2 | -- | $85.8M | $0.37 | -- | -- |
| 04/19/2017 | Q1 | -- | $87.2M | $0.50 | -- | -- |
| 03/08/2017 | Q4 | -- | $81.1M | $0.48 | -- | -- |
| 11/02/2016 | Q3 | -- | $79.9M | $0.55 | -- | -- |
| 08/03/2016 | Q2 | -- | $80.4M | $0.37 | -- | -- |
| 05/04/2016 | Q1 | -- | $76.8M | $0.41 | -- | -- |
| 03/10/2016 | Q4 | -- | $81.5M | $0.38 | -- | -- |
MGP Ingredients, Inc. reported $130.9M worth of top line sales in its most recent quarter.
MGP Ingredients, Inc. announced earnings per share of $0.71 which represents a beat of analyst forecast a $0.60 per share.
MGP Ingredients, Inc. reported $49.4M that represents $2.31 per share over the last quarter.
MGP Ingredients, Inc.'s earnings are forecast to grow from $1.56 per share to $5.58 per share next year representing an increase of 72.33%.
MGP Ingredients, Inc.'s next earnings date is February 25, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.